Literature DB >> 10437772

Revolution in mitochondrial medicine.

N G Larsson1, R Luft.   

Abstract

A revolution in chemical pathology occurred about 40 years ago with the discovery of a patient with mitochondrial dysfunction. The field of mitochondrial medicine has experienced explosive growth during the last decade. More than 50 mtDNA mutations and several nuclear gene mutations have been identified in affected patients. The recent development of animal models will continue the revolution in mitochondrial medicine by facilitating in depth studies of the molecular pathogenesis and development of novel drug and gene therapy strategies for mitochondrial dysfunction. As we enter the next millennium, we can expect mitochondrial medicine to remain a dynamic and rapidly developing field.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10437772     DOI: 10.1016/s0014-5793(99)00854-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Increased mitochondrial mass in mitochondrial myopathy mice.

Authors:  Anna Wredenberg; Rolf Wibom; Hans Wilhelmsson; Caroline Graff; Heidi H Wiener; Steven J Burden; Anders Oldfors; Håkan Westerblad; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-04       Impact factor: 11.205

2.  Trial and error: how the unclonable human mitochondrial genome was cloned in yeast.

Authors:  Brian W Bigger; Ai-Yin Liao; Ana Sergijenko; Charles Coutelle
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

3.  Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  Mol Neurobiol       Date:  2014-10-25       Impact factor: 5.590

4.  Genetic modification of survival in tissue-specific knockout mice with mitochondrial cardiomyopathy.

Authors:  H Li; J Wang; H Wilhelmsson; A Hansson; P Thoren; J Duffy; P Rustin; N G Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

5.  Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.

Authors:  Shanta Dhar; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

Review 6.  Energetic depression caused by mitochondrial dysfunction.

Authors:  Frank Norbert Gellerich; Sonata Trumbeckaite; Tobias Müller; Marcus Deschauer; Ying Chen; Zemfira Gizatullina; Stephan Zierz
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

7.  A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts.

Authors:  Anna Hansson; Nicole Hance; Eric Dufour; Anja Rantanen; Kjell Hultenby; David A Clayton; Rolf Wibom; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

8.  Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures.

Authors:  Pasquale Picone; Rita Carrotta; Giovanna Montana; Maria Rita Nobile; Pier Luigi San Biagio; Marta Di Carlo
Journal:  Biophys J       Date:  2009-05-20       Impact factor: 4.033

9.  Alzheimer's disease: A hypothesis on pathogenesis.

Authors:  D Harman
Journal:  J Am Aging Assoc       Date:  2000-07

Review 10.  Mitochondria: a hub of redox activities and cellular distress control.

Authors:  Poonam Kakkar; B K Singh
Journal:  Mol Cell Biochem       Date:  2007-06-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.